Single-center experience with TruFill @entity902 coils for the embolization of XXXX .

@entity1 @entity68743 @entity1756 @entity439 @entity2300 @entity902 @entity438
Endovascular coiling has become a powerful alternative to neurosurgical clipping of @entity438 . Apart from the @entity68743 (Boston Scientific, Galway, Ireland), there is limited published data about the newer generation of detachable @entity902 coils, e.g., TruFill (Cordis, Johnson and Johnson, Miami, Fl.). We report our initial clinical experience with the embolization of @entity439 by TruFill coils. Included in this retrospective study were 26 @entity1 (age 55.4+/-14.5 years; 9 male, 17 female) with 28 @entity439 , 21 ruptured and 7 unruptured. All @entity1 were treated exclusively by embolization with TruFill @entity902 coils. Immediate angiographic and 6-month angiographic follow-up results were documented. Acute clinical outcome was recorded. Of the 28 @entity439 , 16 (57%) were completely occluded by TruFill embolization, 11 (39%) were @entity2300 with residual necks, and 1 (4%) was partially occluded as @entity439 . There were no @entity1756 during the procedures. Follow-up at 6 months after the procedure was available in 18 @entity1 and 19 @entity439 . Of the 19 @entity439 , 2 of 12 initially completely occluded @entity439 (17%) and 1 of 7 @entity439 with initial residual necks (14%) showed recanalization at the 6-month follow-up. One recanalized @entity439 was subsequently recoiled with consequent residual neck and remained unchanged at the 1-year follow-up. Embolization by TruFill @entity902 coils has a comparable total @entity439 rate to that with @entity68743 . The mid-term reintervention rate is low, and will require verification by future long-term studies.
